Altered states, unmet needs: ethical issues in market authorization for psychedelics

By Christoph Bublitz The return of psychedelics such as psilocybin and LSD to medicine seems imminent. Once associated with the counterculture of the 1960s, these substances have been the subject of serious clinical research for over a decade. In April, the U.S. President signed an Executive Order in support of psychedelic medicine. Shortly thereafter, the […]

Read More…

The illusion of the “benign” cosmetic thyroidectomy: An ethics and teamwork wake-up call

By Behaylu Tesfamaryam Hagos, M.D. Elective surgeries for cosmetic reasons demand the highest level of ethical scrutiny. When a patient undergoes an operation for a benign, asymptomatic condition, driven by societal pressure rather than medical necessity, our tolerance for preventable, life-altering complications should be exactly zero. As an internist, an incidental encounter during a patient’s […]

Read More…

The ontological shift: Why AI in clinical practice is a question of being

Farid bin Masood Much has been written for and against AI’s application in healthcare including screening, prediction, and simulation. But there’s a component of clinical work that matters just as much, maybe more: the clinician’s work as a human, including communicating with the patient and making decisions when faced with uncertainty. Much is being written […]

Read More…

Moving beyond the “Balance Sheet”: How narrative ethics can inform judicial deliberations on treatment refusal

By Prof. Adv. Maya Peled Raz Too often, when courts face the question of forced medical treatment for individuals under guardianship, the conversation quickly narrows to clinical calculations of risk and benefit. As a legal expert and clinical ethics consultant working within the healthcare system, I have often felt that something vital is lost in […]

Read More…

Advertising to the distressed: The commodification of mental health data in AI chatbots

By Nicole Gross and Hannah van Kolfschooten Generative Artificial Intelligence (genAI) chatbots have become an important outlet for many people around the world who are experiencing mental health issues. Of its 800 million weekly users, around 10 percent use ChatGPT for emotional support while more than one million use the chatbot to talk about issues […]

Read More…

The hidden cost of miracle cures

By Dr Peter Carter GLP‑1 weight‑loss drugs are promoted as life‑changing treatments. They help people lose weight quickly and offer a sense of control that many have not felt before. But is this view too short-termist? The central issue is durability. These drugs work while people take them, but the benefits can evaporate when treatment […]

Read More…